White Matter Changes, Duration of Hypertension, and Age Are Associated With Cerebral Microbleeds in Hypertensive Patients of Different Stages
Abstract Purpose We aimed to investigate risk factors for the presence and number of cerebral microbleeds (CMBs) in patients with different hypertension stages, with an emphasis on the relationship between white matter changes (WMCs) and CMBs.Materials and methods Since 2016, participants aged 40 years or more have been evaluated for the presence of CMBs using enhanced 3D multi-echo GE T2*-weighted angiography (ESWAN) sequences. The Mann-Whitney U test and Pearson χ2 test were used to compare the clinical characteristics between the CMB and no-CMB groups of patients. Furthermore, we used Spearman’s rank correlation analyses to examine the association between the degree of CMB severity and other important factors.Results CMBs were detected in 110 (36.7%) of 300 participants. Among patients with stage 2 hypertension, the majority also had CMBs. CMBs were positively correlated with age, hypertension stage, duration of hypertension, WMCs, and silent cerebral infarction. Patients with grade 3 WMCs were significantly more likely to have CMBs than those without WMCs; this association was true for patients with both stage 1 and stage 2 hypertension. In patients with stage 1 or stage 2 hypertension lasting longer than 20 years, the majority had CMBs.Conclusions CMBs detected in hypertensive patients are more likely to occur in deep structures, and the grade of WMCs and duration of hypertension are more closely associated with the CMB degree than with age.Synopsis: The grade of WMCs and duration of hypertension are more closely associated with the CMB degree than with age.